ES2307561T3 - Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima. - Google Patents

Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima. Download PDF

Info

Publication number
ES2307561T3
ES2307561T3 ES01129605T ES01129605T ES2307561T3 ES 2307561 T3 ES2307561 T3 ES 2307561T3 ES 01129605 T ES01129605 T ES 01129605T ES 01129605 T ES01129605 T ES 01129605T ES 2307561 T3 ES2307561 T3 ES 2307561T3
Authority
ES
Spain
Prior art keywords
acid
liquid preparation
stabilized liquid
proenzyme
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01129605T
Other languages
English (en)
Spanish (es)
Inventor
Jurgen Roemisch
Annette Feussner
Christian Kannemeier
Hans-Arnold Stoehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
CSL Behring GmbH Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Behring GmbH Deutschland filed Critical CSL Behring GmbH Deutschland
Application granted granted Critical
Publication of ES2307561T3 publication Critical patent/ES2307561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
ES01129605T 2001-01-08 2001-12-12 Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima. Expired - Lifetime ES2307561T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10100483 2001-01-08
DE10100483 2001-01-08
DE10131404 2001-06-25
DE10131404A DE10131404A1 (de) 2001-01-08 2001-06-25 Stabilisierte Flüssigzubereitung für den Blutgerinnungsfaktor VII aktivierenden Protease oder ihres Proenzyms

Publications (1)

Publication Number Publication Date
ES2307561T3 true ES2307561T3 (es) 2008-12-01

Family

ID=7669938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01129605T Expired - Lifetime ES2307561T3 (es) 2001-01-08 2001-12-12 Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima.

Country Status (3)

Country Link
AT (1) ATE397939T1 (de)
DE (1) DE10131404A1 (de)
ES (1) ES2307561T3 (de)

Also Published As

Publication number Publication date
DE10131404A1 (de) 2002-07-11
ATE397939T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
US7202065B2 (en) Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
ES2344687T3 (es) Formulacion de fibrinogeno liquida, estable en almacenamiento.
ES2654312T3 (es) Preparados de trombina y un procedimiento para su producción
ES2409032T3 (es) Formulaciones liofilizadas de vwf recombinante
ES2241030T3 (es) Preparado farmaceutico para el tratamiento de alteraciones de la coagulacion sanguinea.
KR101212025B1 (ko) 인자 ⅶ 폴리펩티드의 안정화된 고체 조성물
JP2007262090A (ja) 高度に濃縮された、凍結乾燥された、および液体の、因子ｉｘ処方
ES2397234T3 (es) Composiciones estabilizadas de trombina
US20100119563A1 (en) Solid fibrinogen preparation
BRPI0918589B1 (pt) Composições de proteção para fator viii recombinantemente produzido
ES2224917T1 (es) Composiciones farmaceuticas de agente fibrinolitico.
KR20010101028A (ko) 조직 접합제용의 안정화된 단백질 제제
ES2795439T3 (es) Medicamento para tratamiento terapéutico y/o mejoría de la sepsis
JP2017528440A (ja) 第ｖｉｉｉ因子製剤
EP0612530B1 (de) Einen für Tumore cytotoxischen Faktor enthaltende pharmazeutische Zusammensetzung
US5591431A (en) Enhancement of clot lysis
ES2307561T3 (es) Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima.
US5425943A (en) Modified tPA-containing injection composition having increased solubility
JP2971680B2 (ja) 組織プラスミノーゲン活性化因子含有組成物
JP2024513983A (ja) 第ｖｉｉｉ因子または第ｖｉｉｉ因子／フォン・ヴィレブランド因子複合体を含む液体組成物
NZ733837B2 (en) Pharmaceutical composition comprising plasminogen and uses thereof
JPH09176041A (ja) α２プラスミンインヒビターを含有するＤＩＣ治療用薬剤